
To zzso data obtained over a zzso period to determine the efficacy and safety of an intravenous zzso zzso zzso 

IV zzso was provided on a compassionate plea basis to patients of any age in whom zzso zzso inhibitor therapy was indicated as an adjunct to chemotherapy and for whom oral intake was zzso Three hundred zzso investigators at multiple hospitals in the United States treated zzso patients with IV zzso The vast majority of these patients had a zzso and were in danger of developing tumor zzso syndrome zzso and subsequent acute zzso acid zzso zzso and were unable to take oral zzso Data zzso to the time period of IV zzso administration were collected, zzso and analyzed zzso There was no zzso 

In patients initiating treatment for an elevated serum zzso acid zzso the zzso zzso or improved in zzso of adult patients and zzso or improved in zzso of pediatric zzso IV zzso administered zzso to patients at high risk of developing zzso and zzso prevented an increase in zzso levels in zzso of adults and zzso of zzso zzso caused by IV zzso were minimal and consisted of 10 instances of mild to moderate skin or allergic zzso 

IV zzso is as zzso and safe as oral zzso and will be of significant benefit to patients at risk of zzso and zzso and unable to take oral zzso 

